To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

ISASS: Use of rhBMP-2 and autologous bone in PLIF display similar clinical outcomes

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2013

ISASS: Use of rhBMP-2 and autologous bone in PLIF display similar clinical outcomes

Vol: 2| Issue: 3| Number:108| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

The Effect of rhBMP-2 in one-level PLIF

Contributing Authors:
J Michielsen J Sys

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

40 patients undergoing posterior lumbar interbody fusion (PLIF) were randomized to receive polyetheretherketone (PEEK) cages filled with either recombinant human bone morphogenic protein (rhBMP-2) or autologous bone to compare their clinical and radiological effects. At 24 months, the incidence of end plate resorption, osteolysis, and ectopic bone formation were frequently observed with rhBMP-2; h...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.